Published in Gastrointest Endosc Clin N Am on January 01, 2002
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature (2012) 4.41
Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history. Lancet Oncol (2013) 1.83
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) (2012) 1.48
Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37
Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol (2012) 1.21
Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol (2013) 1.14
Rectal mucosal microvascular blood supply increase is associated with colonic neoplasia. Clin Cancer Res (2009) 1.09
Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol (2011) 1.07
Risk of advanced colorectal neoplasia according to age and gender. PLoS One (2011) 1.05
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis (2014) 1.04
Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population. Gut (2007) 1.00
An evidence-based microsimulation model for colorectal cancer: validation and application. Cancer Epidemiol Biomarkers Prev (2010) 0.98
CT colonography for population screening: ready for prime time? Dig Dis Sci (2014) 0.97
The relationship between distal and proximal colonic neoplasia: a meta-analysis. J Gen Intern Med (2011) 0.97
Detection of colonic polyps according to insertion/withdrawal phases of colonoscopy. Int J Colorectal Dis (2009) 0.95
Reduction of the incidence and mortality of rectal cancer by polypectomy: a prospective cohort study in Haining County. World J Gastroenterol (2002) 0.93
The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy. BMC Gastroenterol (2011) 0.91
A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study. BMC Cancer (2012) 0.87
CT colonography without cathartic preparation: positive predictive value and patient experience in clinical practice. Eur Radiol (2012) 0.87
A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy. Am J Gastroenterol (2015) 0.87
CT colonography in the diagnosis and management of colorectal cancer: emphasis on pre- and post-surgical evaluation. World J Gastroenterol (2014) 0.87
Determinants of polyp size in patients undergoing screening colonoscopy. BMC Gastroenterol (2011) 0.86
Evolution of Screen-Detected Small (6-9 mm) Polyps After a 3-Year Surveillance Interval: Assessment of Growth With CT Colonography Compared With Histopathology. Am J Gastroenterol (2015) 0.83
Volumetric texture features from higher-order images for diagnosis of colon lesions via CT colonography. Int J Comput Assist Radiol Surg (2014) 0.83
Follow-up after colorectal polypectomy: a benefit-risk analysis of German surveillance recommendations. Int J Colorectal Dis (2007) 0.83
Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open (2014) 0.82
Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy. Int J Cancer (2015) 0.81
Computer tomography colonography participation and yield in patients under surveillance for 6-9 mm polyps in a population-based screening trial. Eur Radiol (2015) 0.80
Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas. BMC Cancer (2006) 0.80
Risk assessment and clinical decision making for colorectal cancer screening. Health Expect (2013) 0.80
Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial. Med Decis Making (2016) 0.79
Television watching and risk of colorectal adenoma. Br J Cancer (2015) 0.79
Barrett's metaplasia and colonic neoplasms: a significant association in a 203,534-patient study. Dig Dis Sci (2013) 0.79
Colorectal cancer screening in African Americans: practice patterns in the United States. Are we doing enough? Gastroenterol Rep (Oxf) (2016) 0.78
Laterally spreading tumors: limitations of computed tomography colonography. World J Gastroenterol (2014) 0.78
The history of colorectal cancer screening: a personal perspective. Dig Dis Sci (2015) 0.78
The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis. Br J Radiol (2016) 0.77
Development of a Novel Scoring System for Predicting the Risk of Colorectal Neoplasia: A Retrospective Study. PLoS One (2016) 0.77
Experience of a public health colorectal cancer testing program in Maryland. Public Health Rep (2012) 0.77
Blood lipids and colorectal polyps: testing an etiologic hypothesis using phenotypic measurements and Mendelian randomization. Cancer Causes Control (2015) 0.77
Colorectal Polyps Missed with Optical Colonoscopy Despite Previous Detection and Localization with CT Colonography. Radiology (2015) 0.77
Management of subcentimetric polyps detected by CT colonography. Nat Rev Gastroenterol Hepatol (2012) 0.77
A prediction model for colon cancer surveillance data. Stat Med (2015) 0.76
Virtual colonoscopy vs optical colonoscopy. Expert Opin Med Diagn (2010) 0.75
Importance of reporting segmental bowel preparation scores during colonoscopy in clinical practice. World J Gastroenterol (2015) 0.75
Predictive cytogenetic biomarkers for colorectal neoplasia in medium risk patients. J Med Life (2015) 0.75
Computed tomography colonography for the practicing radiologist: A review of current recommendations on methodology and clinical indications. World J Radiol (2016) 0.75
Risk Factors of Advanced Adenoma in Small and Diminutive Colorectal Polyp. J Korean Med Sci (2016) 0.75
Sensitivity of 2-[(18)F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals. J Gastroenterol (2016) 0.75
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation (2006) 2.68
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50
Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2008) 2.47
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) (2009) 2.46
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31
Statin use and the risk of breast and prostate cancer. Epidemiology (2002) 2.15
Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer (2009) 1.88
National Polyp Study data: evidence for regression of adenomas. Int J Cancer (2004) 1.83
A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making (2011) 1.77
Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making (2011) 1.71
C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res (Phila) (2011) 1.57
Colonoscopy surveillance after polypectomy and colorectal cancer resection. Am Fam Physician (2008) 1.52
Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care (2008) 1.37
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med (2014) 1.32
Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol (2004) 1.32
Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev (2007) 1.25
Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. J Natl Cancer Inst (2012) 1.25
Stool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysis. Ann Intern Med (2010) 1.24
Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev (2009) 1.23
Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2010) 1.20
Much of the genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas. Gastroenterology (2012) 1.15
Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control (2008) 1.14
Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control (2009) 1.13
High-quality colonoscopies must be an integral part of screening and surveillance programs. Gastroenterology (2006) 1.12
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med (2016) 1.10
Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR Am J Roentgenol (2011) 1.07
Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf (2002) 1.00
Adherence to the dietary guidelines for Americans and endometrial cancer risk. Cancer Causes Control (2010) 0.98
Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. Gastroenterology (2009) 0.97
The economic impact of a patient navigator program to increase screening colonoscopy. Cancer (2012) 0.89
Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. Cancer (2005) 0.88
Changes in risk factors and increases in screening contribute to the decline in colorectal cancer mortality, 1975 to 2000. Gastroenterology (2010) 0.86
Coffee and tea consumption and endometrial cancer risk in a population-based study in New Jersey. Cancer Causes Control (2010) 0.83
Derivation of background mortality by smoking and obesity in cancer simulation models. Med Decis Making (2012) 0.80
Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study. Clin Cancer Res (2013) 0.80
Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information. Med Decis Making (2012) 0.79
The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer Prev Res (Phila) (2011) 0.79
United States Preventive Services Task Force recommendations: age to end screening misunderstood. Dis Colon Rectum (2010) 0.78
Incidence reduction following colonoscopic polypectomy. Am J Gastroenterol (2011) 0.78
Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy. J Med Screen (2013) 0.78
Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations. Radiology (2011) 0.78
On finding flat adenomas: is the search worth the gain? Gastroenterology (2002) 0.77
Simulation of colorectal cancer screening: what we do and do not know and does it matter. Best Pract Res Clin Gastroenterol (2010) 0.77
Prostaglandin inhibition and cardiovascular risk: maybe timing really is everything. Cancer Prev Res (Phila) (2009) 0.76
Quality control for flexible sigmoidoscopy: which polyps count? Gastroenterology (2004) 0.76
Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening. Med Care (2015) 0.76
Extracolonic findings from CTC: balancing risks and benefits. AJR Am J Roentgenol (2009) 0.75
A restricted look at CRC screening: not considering annual stool testing as an option. Am J Manag Care (2016) 0.75
Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing. J Clin Gastroenterol (2017) 0.75
Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy. Epidemiol Rev (2017) 0.75